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1. Introduction
Bone augmentation procedures are often necessary for the successful placement of
endosseous dental implants. Several treatment modalities have been developed for bone
growth, including distraction osteogenesis, onlay bone grafting, and guided bone
regeneration (GBR). Guided bone regeneration may be used for either vertical
augmentation or horizontal augmentation, and clinical studies will be presented that
demonstrate the clinical significance of these types of procedures.
1.1 Vertical Augmentation with GBR
Supracrestal or vertical bone augmentation presents one of the greatest challenges
of bone regeneration in implant dentistry. This is primarily due to the difficulty of the
surgical procedure and its potential complications. Supracrestal augmentation aims to
achieve bone regeneration in a direction without bony walls to support the stability of the
bone graft. It is demanding biologically, because bone regeneration and angiogenesis has
to reach a distance from the existing bone. In addition, the soft tissue has to be advanced
to provide a closed healing environment for the increased dimension of the healing bone
graft. Several treatment modalities have been developed for vertical bone growth,
including distraction osteogenesis, onlay bone grafting, and vertical guided bone
regeneration (GBR).
The application of GBR for supracrestal regeneration was introduced and the
surgical technique described (Tinti and Parma-Benfenati 1998). There are few reports of
vertical GBR, and they present conflicting results and relatively high complication rates.
The first animal and human histologic studies demonstrated successful vertical bone
augmentation (Jovanovic et al. 1995; Simion et al. 1994). Complications reported with
vertical augmentation involved membrane exposure and/or subsequent infection, with
rates ranging between 12.5% and 17% (Tinti and Parma-Benfenati 1998; Simion et al.
1994, 1998).
The long-term results of vertical GBR following 1 to 5 years of prosthetic loading
were examined in a retrospective multicenter study evaluating 123 implants (Simion et al.
2001). Three treatment modalities (non-resorbable regenerative membranes in
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combination with blood clot only, demineralized freeze-dried bone allograft (DFDBA),
or autogenous bone chips) were studied and the results from this investigation revealed
that vertical bone regeneration superior to 4 mm could only be achieved with the use of
autogenous bone chips. These authors reported an overall success rate of 97.5%, leading
them to conclude that vertically augmented bone using GBR techniques responds to
implant placement in a fashion similar to native, non-regenerated bone. In another study,
the GBR technique for vertical augmentation was used in combination with a sinus lift
procedure for posterior maxillary reconstruction (Simion et al 2004). However, the
implant survival and success rates were 92.1% and 76.3%, respectively, which conflicted
with previously reported results on vertical and horizontal GBR (Buser et al 2002;
Simion et al 2001). All these studies utilized non-resorbable, titanium reinforced,
expanded polytetrafluoroethylene (e-PTFE) membranes (GORE-TEX® Regenerative
Material Titanium Reinforced or GTRM-TR, W.L. Gore & Associates, Flagstaff, AZ).
These membranes have been associated with a high incidence of soft tissue problems,
such as exposure (Zitzmann 1997). Other authors have reported a similar soft tissue
response of e-PTFE membranes when compared to resorbable membranes (Simion
1997). Titanium osteosyntheis plates covered with a collagen resorbable membrane was
compared to e-PTFE membranes in a randomized clinical trial for vetical GBR, and
there were no statistically significant differences in terms of complications between the
two techniques (Merli et al 2006). In addition, more sites achieved a complete
regenerative outcome when the e-PTFE membrane was used. No long-term results were
reported of implants placed into vertically regenerated bone when particulated bone graft
materials was covered with titanium osteosntheis plates and a resorbable membrane.
Hence, the utilization of e-PTFE membranes represents the current state of the science in
vertical GBR.
1.2 Horizontal Augmentation with GBR
Augmentation utilizing guided bone regeneration (GBR) has become a major
treatment option to provide optimal bone support for osseointegrated dental implants.
Simple defects were initially treated with GBR, including dehiscence and fenestration
defects (Aghaloo & Moy 2007; Esposito et al 2006a; Hämmerle et al 1998, 2002; Dahlin
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et al 1991; Jovanovic et al 1992; Lorenzoni 1998; Zitzmann et al 2001a; Moses et al
2005). In addition, GBR has been utilized for horizontal and vertical ridge
augmentations( Hämmerle et al 1998; Dahlin et al 1991; Jovanovic et al 1992; Lorenzoni
1998; Zitzmann et al 2001a; Moses et al 2005; Simion et al 2001; Buser et al 2002;
Urban et al 2009 a, b) and has demonstrated reproducible outcomes with high implant
survival rates and low complication rates (Esposito et al 2006b).
The so called “knife-edge” ridges, or Cawood and Howell Class IV edentulous
jaw (Cawood & Howell 1988), present a unique problem for horizontal augmentation.
The necessary height of the ridge is adequate on the lingual/palatal side, but the width is
insufficient making implant placement often impossible without prior treatment
(Proussaefs & Lozada 2003). However, there is a good prognosis for this treatment as the
residual ridge can be used to stabilize the bone graft, making it less subject to movement,
one of the factors that may lead to a failure. To avoid movement of the bone graft,
autogenous bone blocks are often screwed onto the ridge to ensure stability and
subsequent new bone formation (von Arx & Buser 2006; Cordaro et al 2002; Schenk et al
1994; Buser et al 1996). Bone blocks (also referred to as “onlay bone graft”) can be
fixated onto the residual ridge, providing a limited number of additional bone forming
cells into the augmentation site, and may eliminate the use of a non-resorbable titanium
reinforced membranes (Chiapasco et al 1999). Studies of onlay bone grafting have
reported 60% to 100% implant survival rates, with the majority of reported survival rates
> 90% (Aghaloo & Moy 2007; Chiapasco et al 2006). However, block bone grafts are
associated with varying morbidity depending on the harvest site (Nkenke et al 2001,
2004; Raghoebar et al 2001) and early resorption that could compromise clinical outcome
(von Arx & Buser 2002; Maiorana et al 2005). Thus for partially edentulous patients it
has been recommended that the utilization of GBR may be an alternative grafting
procedure for patients presenting with advanced ridge atrophies (Chiapasco et al 2006).
Clinical studies utilizing GBR for the treatment of knife-edge ridges used both
non-resorbable and resorbable membranes (Buser et al 2002; Hämmerle et al 2008). To
obtain the anticipated volume of the ridge, utilizing GBR, autogenous bone or bone
substitutes are placed under the barrier membrane to prevent collapse of the augmentation
volume (Lindhe et al 2003).
8
Resorbable membranes have shown better soft tissue compatibility, compared to
non-resorbable membranes (Friedmann et al 2002; Zitzmann et al 1997, 2001a). Reports
of clinical and preclinical animal studies have demonstrated that a resorbable membrane
in combination with particulated bone or bone substitute can be used for the treatment of
knife-edge ridges. Friedmann et al. (2002) reported on a clinical study using a slowly
resorbing collagen membrane in combination with anorganic bovine-derived bone
mineral (ABBM) for the augmentation of horizontally deficient ridges. Good results
were obtained, but the handling of the collagen membrane was technique sensitive as has
been observed with non-resorbable membranes (Chiapasco et al 1999). Hämmerle et al.
(2008) have used ABBM in combination with a collagen membrane, and concluded this
was an effective treatment for horizontal ridge augmentation. Similarly, Zitzmann et al.
(2001b) have performed a histologic analysis in defects that had been filled with ABBM
and covered with a collagen membrane. Their results indicated that ABBM may be a
suitable material for staged localized ridge augmentation. As an additional osteogenic
component, particulated autogenous bone can be mixed with bone substitutes to add more
osteogenic factors and a limited number of osteogenic cells to the augmentation site.
The potential advantages of this treatment modality compared to autogenous bone
block application are an increased exposure of osteoinductive growth factors and greater
osteconductive surface. Autogenous bone can be mixed with ABBM: harvesting less
autogenous bone may result in a decreased morbidity from this procedure.
Traditional synthetic membranes have demonstrated therapeutic problems using
traditional polymers like polylactic acid because of their inflammatory and foreign body
reaction upon degradation (von Arx et al 2005). More recent experimental results with a
newly developed synthetic resorbable membrane made of polyglycolic acid (PGA) and
trimethylene carbonate (TMC) have yielded positive results. Recent studies in an animal
model with this membrane have demonstrated no histologic foreign body or
inflammatory reaction (Stavropoulos et al 2004). This synthetic resorbable membrane
has been designed to slowly resorb over 4-6 months, providing a prolonged barrier
function to ensure that the newly formed bone has sufficient time to mature before soft
tissue can grow into it.
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In vitro and preclinical animal studies with native collagen membranes have
shown excellent biocompatibility and demonstrated equivalent bone formation in
dehiscence-type defects when this more rapidly resorbing native collagen membrane was
compared to non-resorbable and slowly resorbing membranes (Rothamel et al 2004;
Schwarz et al 2008). These nonclinical results and the case series using the native
collagen membrane (Hämmerle et al 2008) may indicate that a slowly resorbing
membrane is not necessary for horizontal augmentation.
2. AIM OF THE STUDIES
Three studies will be presented: a retrospective study that utilized vertical augmentation;
a horizontal augmentation study that utilized a new synthetic membrane (this study is
referred to as “HA/1”); and a horizontal augmentation study that utilized a native, bilayer
collagen membrane (this study is referred to as “HA/2”).
2.1 Study on Vertical Augmentation
The aims of this retrospective study were to: (1) evaluate results of vertical GBR
with particulated, autogenous bone grafts; (2) determine clinical and radiographic success
and survival rates of implants placed in surgical sites after prosthetic loading; and (3)
compare success and survival rates of implants placed in defects
treated simultaneously with sinus augmentation and vertical GBR to other areas treated
with vertical GBR only.
2.2 Horizontal Augmentation Utilizing a New Synthetic Membrane (HA/1).
The purpose of this clinical series was to evaluate clinically and histologically the
possibility of using a new synthetic resorbable membrane in combination with a mixture
of anorganic bovine bone mineral (ABBM) and autogenous particulated bone in
horizontal augmentation of knife-edge ridges.
2.3 Horizontal Augmentation Utilizing a Native, Bilayer Collagen Membrane
(HA/2)
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The use of a more rapidly resorbing native collagen membrane and 1:1 mixture of
autogenous particulated bone/ABBM as grafting material for horizontal augmentation has
not yet been investigated. Accordingly, the purpose of this clinical series was to evaluate
clinically and histologically the use of a more rapidly resorbing native collagen
membrane in combination with a mixture of ABBM and autogenous particulated bone in
horizontal augmentation of knife-edge ridges to confirm the acceptability of the
osteoconductive material in the procedure and to limit the amount of harvested
autogenous bone required for the procedure.
3. MATERIALS AND METHODS
3.1 Vertical Augmentation
This retrospective study reported on patients who were consecutively treated with
vertical augmentation using GBR and particulated autografts from June 1999 to Oct
2004. All patients were treated at either the Center for Implant Dentistry (Loma Linda
University School of Dentistry, Loma Linda, CA, USA) or in a private clinic (Budapest,
Hungary). All surgical procedures were performed by the same practitioner (I.U.) with
over 15 years of experience in oral surgery and implant therapies, and the prosthetic
treatments were performed by residents in the Loma Linda University Implant Dentistry
program or private practitioners.
Inclusion criteria: Cases were selected that required vertical bone regeneration (1) to
achieve the necessary bone levels in order to place dental implants, and (2) to improve
the crown/implant ratio and esthetics. Patients were required to have good oral hygiene
prior to treatment.
Exclusion criteria: Patients were excluded if they were current smokers; engaged in
excessive alcohol consumption; or had uncontrolled systemic conditions or uncontrolled
periodontal disease.
Clinical Procedures: Briefly, all patients were treated with vertical ridge augmentation
utilizing titanium reinforced, non-resorbable, expanded polytetrafluoroethylene (e-PTFE)
membranes (GORE-TEX® Regenerative Membrane Titanium Reinforced or GTRM-TR,
W.L. Gore & Associates, Flagstaff, AZ, USA) and particulated autografts.
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Defects were measured during the grafting procedures with a calibrated
periodontal probe. Vertical bone defects were measured from the most apical portion of
the bony defect to a line connecting the interproximal bone height between neighboring
teeth, or to the original bone crest of the edentulous area.
The surgical technique has been described previously (Tinti et al 1998). Briefly, a
remote full-thickness flap was elevated in the edentulous area and the residual bone ridge
was prepared carefully to receive an autogenous bone graft and a GTRM-TR membrane.
The autografts were harvested from the mandible, particulated in a bone mill (R. Quétin
Bone-Mill, Roswitha Quétin Dental Products, Leimen, Germany), and applied to the
defect. The bone graft was immobilized and covered with a GTRM-TR membrane that
was stabilized with titanium bone tacks. When implants were placed simultaneously, the
fixtures protruded from the base of the defect to the desired vertical position, and were
covered with the graft and membranes.
In posterior maxillary cases with both severe vertical crestal bone atrophy and
enlarged maxillary sinus, a combined procedure of vertical GBR and a simultaneous
maxillary sinus graft was used. The sinus grafts utilized the lateral window approach and
the grafting material consisted of autogenous particulated bone with anorganic bovine
spongiosa bone mineral (Bio-Oss®, Geistlich Pharma AG, Wolhusen, Switzerland). The
classification and rationale for this procedure with posterior maxillary alveolar defects
that combines GBR and sinus bone grafts have been described previously (Jovanovic &
Altman 1998; Simion et al 2004). Bone harvest sites were selected based on the amount
of bone required versus available bone and anatomic limitations. Clinical photographs
were taken during the procedures. See Figure 1 (a and b graphically present parts of the
surgical procedure).
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Figure 1. Vertical Augmentation Study: Measurement of representative defect before
and after treatment. (a) A 7-mm vertical defect involving 3 teeth. (b) Buccal view of the
autogenous bone graft and membrane in place. (c) and (d) Regenerated bone crest at
membrane removal after 9 months of healing.
(a) (b)
(c) (d)
The surgical site was allowed to heal for 6 to 9 months. Then, the GTRM-TR
membranes were removed, and implants were placed or uncovered. At the time of
membrane removal, bone regeneration was evaluated (see Figures 1c and 1d). At
implant placement, a collagen membrane (Bio-Gide® Resorbable Bilayer Membrane,
Geistlich Pharma AG, Wolhusen, Switzerland) was placed over the newly formed crestal
bone to protect the graft from early resorption. The objective was to place the implant
platform to crestal bone level, leave in submerged healing for 6 months, then uncover the
implants.
All patients were to receive a provisional prosthesis during the healing phase of
the bone grafts and the implants in order to provide function and esthetics, and no
13
pressure to the site. Final restorations were to occur within a few weeks after the
implants were uncovered. Patients received fixed implant-supported restorations and
entered into a scheduled maintenance program that included a clinical examination every
six months and annual radiographic examination.
Clinical examination: Peri-implant mucosal conditions were assessed for redness,
hyperplasia, suppuration, swelling, and presence of plaque. Probing depths were recorded
according to established methods (Buser et al 1990, 2002; Van Steenberghe et al 1990).
Radiographic examination: Periapical radiographs were taken at the abutment connection
and then every 12 months thereafter with a long cone parallelling technique. Crestal
bone levels were measured up to 0.01 mm using NIH image software, with the implant
abutment junction as the baseline reference (Wyatt et al 2001).
Complications: Complications in bone graft healing, such as membrane exposure and/or
subsequent infection, were recorded.
Implant Success Criteria: Success was evaluated according to established methods that
evaluated the following : absence of pain, foreign body sensation, dyesthesia, mobility, or
peri-implant radiolucency. Following the first year of function, there could be ≤ 0.2mm
crestal bone remodeling annually (Albrektsson et al 1986), and ≤ 2.0 mm total crestal
bone remodeling by the end of the fifth year was considered acceptable (Wennstrom &
Palmer 1999).
Statistical Analysis:
Recorded data were used for calculations of mean values and standard deviations (SD).
Cumulative Success Rates (CSR) were evaluated using life table analysis (Colton 1974).
Significant differences in marginal bone level changes between three groups were
assessed by t-tests, employing a critical p-value of 0.0167 to account for multiple
comparisons.
3.2 Horizontal Augmentation Utilizing a New Synthetic Membrane (HA/1).
This case series reported on patients who were consecutively treated in the
posterior mandible or maxilla with horizontal augmentation using GBR and particulated
autografts from January 2003 through May 2006. All patients required augmentation of a
“knife-edge” ridge for subsequent implant placement, including some patients (17 out of
14
22 maxillary cases) who also required a sinus floor elevation. All patients were treated in
a private practice (Budapest, Hungary), and all surgical procedures were performed by
the same practitioner (I.U.) with over 15 years of experience in oral surgery and implant
therapies. The prosthetic treatments were performed and restored by the author (I.U.) and
other private practitioners.
Patients in good physical health and the ability to maintain good oral hygiene
were treated with the new resorbable membrane and bone graft. All patients were fully
informed about the whole treatment prior to the first surgical procedure and gave written
consent for the procedure. Patients were not eligible for this treatment if they were
current smokers, engaged in excessive alcohol consumption, or had uncontrolled
systemic conditions or uncontrolled periodontal disease.
All patients were treated with horizontal ridge augmentation using a recently
developed synthetic barrier membrane composed of a microporous structure of synthetic
bioabsorbable glycolide and trimethylene carbonate copolymer fiber (GORE RESOLUT®
ADAPT® LT Regenerative Membrane, W.L. Gore & Associates, Inc., Flagstaff, AZ).
This membrane was developed with a new chemical composition and ratio of the
components with the aim of a longer resorption time of 4 to 6 months. Either autogenous
bone or a combination of autogenous bone and anorganic bovine bone-derived mineral
(ABBM, Bio-Oss®, Geistlich Pharma AG, Wolhusen, Switzerland). The first 7 patients
were treated with autogenous bone alone to confirm the technique and use of the new
membrane. Subsequent patients were treated with a combination of autogenous bone and
ABBM to confirm the acceptability of a new osteoconductive material in the procedure
and to limit the amount of harvested autogenous bone required for the procedure.
Patients were pre-medicated with amoxicillin 2 g one hour before surgery and 500
mg penicillin three times a day for one week following the surgery. In the event of a
penicillin allergy, clindamycin 600 mg was used for premedication and 300 mg four
times a day for one week following surgery. Oral sedation, usually Triazolam 0.50 mg
(Halcion), was also frequently administered one hour prior surgery. Patients were
instructed to rinse with 0.2% chlorhexidine solution (e.g., Corsodyl) for one minute to
disinfect the surgical site and a sterile surgical drape was applied to minimize the
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potential contamination from extraoral sources. A local anesthetic (Septanest with
adrenaline 1/100,000) was applied.
The flap design was chosen to ensure primary tension-free closure after the bone
grafting procedure despite the increased dimension of the ridge. A remote flap was
performed including crestal and vertical releasing incisions. A full thickness, mid-crestal
incision into the keratinized gingiva was performed with a surgical scalpel. The two
divergent vertical incisions were placed at least one tooth away from the surgical site. In
edentulous areas, the vertical incisions were placed at least 5 mm away from the
augmentation site. After primary incisions, periosteal elevators were used to reflect a full
thickness flap beyond the mucogingival junction and at least 5 mm beyond the bone
defect. In the posterior mandible, the lingual flap was elevated beyond the linea
milohyoidea and anatomical locations, like the mental and the infra-orbital nerves, were
protected.
Grafting: After flap elevation and evaluation of the defect size, autogenous bone was
harvested from the retromolar regions using a trephine burr. For posterior mandibular
sites, the bone harvest was performed on the same side and the harvest site preparation
was included in the flap design. For maxillary sites, an additional flap was created in the
posterior mandible for bone harvesting.
The harvested graft was particulated in a bone mill (R. Quétin Bone-Mill,
Roswitha Quétin Dental Products, Leimen, Germany) and then either applied alone or
after preparing a 1:1 mixture with ABBM (the combination is referred to as “composite
bone graft”). The bone of the exposed augmentation site was cleaned of all soft tissue
remnants prior to grafting. Ridge measurements were taken and are described in a
section below. The recipient bone bed was prepared with multiple decorticalization holes
using a small round burr.
The new synthetic membrane was trimmed to the volume of the graft, and care
was taken to avoid contact with the edges of the adjacent teeth. The membrane was fixed
to at least at two points on the lingual/palatal sides with titanium pins. The autogenous
particulated bone graft or composite bone graft was placed into the defect, and the
membrane was folded over and fixed in place with additional titanium pins on the
vestibular side.
16
Additional grafting: For maxillary cases with a sinus proximity (17 of the 21 maxillary
cases), additional sinus floor augmentation was performed. No other combination
grafting procedures were performed.
Soft tissue management: Once the membrane was completely secured, the flap was
mobilized to permit tension free, primary closure. A periosteal releasing incision
connecting the two vertical incisions was performed to achieve elasticity of the flap. The
flap was than sutured in two layers: first horizontal mattress sutures (GORE-TEX® CV-5
Suture, W.L. Gore & Associates, Inc., Flagstaff, AZ) were placed 4 mm from the incision
line; then, single interrupted sutures with the same ePTFE suture were placed to close the
edges of the flap, leaving at least a 4 mm thick connective tissue layer between the
membrane and the oral epithelium. This intimate connective tissue-to-connective tissue
contact provides a barrier preventing exposure of the membrane. Vertical incisions were
closed with single interrupting sutures.
The single interrupted sutures were removed between 10 to 14 days post surgery,
and mattress sutures were removed after two to three weeks.
Measurements of the alveolar ridge width were taken intra-surgically, at the
original surgery and then after the healing phase before preparation of the implant bed.
The same calliper was used to take all measurements 2 mm apically from the top of the
crest.
Complications in bone graft healing, such as membrane exposure, subsequent
infection, and/or morbidity associated with the harvest site, were recorded,
Periapical radiographs were taken at the abutment connection and then every 12
months thereafter with a long cone parallelling technique.
Functionally loaded implants were monitored to evaluate the following: Absence
of pain, foreign body sensation, dyesthesia; Radiological contact between the host bone
and the implant surface.
Figures 2 and 3 present the surgical methods utilized in this study.
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Figure 2: HA/1 Study: Representative case of autogenous bone only as grafting
material. (a) Occlusal view of posterior maxillary area presents thin bone crest. (b)
Buccal view of the defected area presents elevated maxillary sinus and the recipient bone
bed is prepared with multiple decorticalization holes. (c) Autogenous particulated bone is
in place. (d) Membrane is fixated with titanium pins. (e, f) After 6 months of uneventful
healing, occlusal view of the augmented bone crest. Two implants are in position. (g)
Final prosthetic reconstruction. (h) Peri-apical radiograph after 5 years of function.
(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 3: HA/1 Study: Representative case of 1:1 mixture of autogenous particulated
bone and ABBM as grafting material: Posterior mandibular site. (a) Occlusal view of the
site showing the knife edge ridge. (b) Buccal view after application of a mixture of
autogenous particulated bone and ABBM granules, the synthetic resorbable membrane is
secured over the graft with titanium pins. (c) Sutured defect ensuring primary tension free
wound closure. (d) Re-entry surgery after 8 months revealing sufficient bone width to
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place dental implants. (e) Implant placed into the augmented ridge. (f) Final prosthetic
reconstruction. (g) Radiographs after 12 months of loading
(a) (b)
(c) (d)
(e) (f)
(g)
At the time of implant placement, cylindrical biopsies were obtained from
selected healed and augmented surgical sites using a trephine burr with an inner diameter
of 2.0 mm.
Specimens were fixated in 4 percent formaldehyde. Before processing they were
rinsed in water and dehydrated in alcohol (70%, 80%, 90%, 100%) for 3 days in each
concentration and then defatted for 1 day in Xylol (Merck, Darmstadt, Germany).
Specimens were transferred for 2 weeks in a mixture of methyl methacrylate (MMA,
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Methylmetacrylat, Merck, Darmstadt, Germany) and 15% Dibuthylphthalat (Fluka,
Steinheim, Germany) and then placed for one day in a mixture of MMA, 15%
Dibuthylphthalat, and 1.5% dried Benzolperoxid (Merck, Darmstadt, Germany).
Infiltration took place in an airproof sealed glass envelope for 2 weeks in a
polymerization mixture of MMA (Methylmetacrylat, Merck, Darmstadt, Germany), 15%
Dibuthylphthalat and 3% dried Benzoyl peroxide at room temperature. Sections were
then ground to a thickness of 80 µm on a rotating grinding plate (Stuers, Ballerup,
Denmark).
Optical microscopy specimens were stained according to the procedure described
by Richardson et al (1960). Azur II (Merck, Darmstadt, Germany) was used for the
exposition of the soft tissue and Pararosalin (Sigma-Aldrich, Deisenhofen, Germany) for
the differentiation of native and new bone. Imaging was performed with a microscope
(Carl Zeiss, Göttingen, Germany) and a digital camera (CC-12, Soft Imaging System,
Münster, Germany). Images were optimized and evaluated with the program Analysis
(Soft Imaging System, Münster, Germany).
Statistical Analysis:
All data were analyzed by descriptive methods, and means, standard deviations,
medians, and interquartile ranges were calculated using SAS statistical software (version
9.1.3, Cary, North Carolina). Implant survival was estimated using life table analysis.
3.2 Horizontal Augmentation Utilizing a Native, Bilayer Collagen Membrane
(HA/2).
This case series reports on patients who were consecutively treated in the
posterior mandible or maxilla with horizontal augmentation using GBR and particulated
autografts from March 2007 through February 2010. All patients required augmentation
of a “knife-edge” ridge for subsequent implant placement (Cawood-Howell class IV),
including some patients who also required a sinus floor elevation. All patients were
treated in a private practice (Budapest, Hungary), and all surgical procedures were
performed by the same practitioner (I.U.) with over 15 years of experience in oral surgery
and implant therapies. The prosthetic treatments were performed and restored by the
author (I.U.) and other private practitioners.
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Patients in good physical health and the ability to maintain good oral hygiene
were treated with the new resorbable membrane and bone graft. All patients were fully
informed about the whole treatment prior to the first surgical procedure and gave written
consent for the procedure. Patients were not eligible for this treatment if they were
current smokers, engaged in excessive alcohol consumption, or had uncontrolled
systemic conditions or uncontrolled periodontal disease.
All patients were treated with horizontal ridge augmentation using a bilayer
resorbable membrane derived from native collagen (Bio-Gide® Resorbable Bilayer
Membrane, Geistlich Pharma AG, Wolhusen, Switzerland) and a combination of
autogenous bone and anorganic bovine bone-derived mineral (ABBM, Bio-Oss®,
Geistlich Pharma AG, Wolhusen, Switzerland). See Figures 4 and 5 (below) for a
graphic presentation of the surgical procedure.
Patients were pre-medicated with amoxicillin 2 g one hour before surgery and 500
mg penicillin three times a day for one week following the surgery. In the event of a
penicillin allergy, clindamycin 600 mg was used for premedication and 300 mg four
times a day for one week following surgery. Oral sedation, usually Triazolam 0.50 mg
(Halcion), was also frequently administered one hour prior to surgery. Patients were
instructed to rinse with 0.2% chlorhexidine solution (e.g., Corsodyl) for one minute to
disinfect the surgical site and a sterile surgical drape was applied to minimize the
potential contamination from extraoral sources. A local anesthetic (articaine
hydrochloride 4% with epinephrine bitartrate 1/100,000) was applied.
Figure 4: HA/2 Study: Treatment scheme of a representative case of horizontal
augmentation in the posterior maxilla. (a, b) Occlusal and buccal views of posterior
maxillary area presents thin bone crest. (c) The collagen membrane is fixated on the
palatal area. Autogenous particulated bone mixed with ABBM in place. (d) Tension free
flap closure with double-layer suturing. (e,f) Buccal and occlusal views of regenerated
bone crest. (g) Periapical radiograph demonstrates stable crestal bone level after loading.
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(a) (b)
(c) (d)
(e) (f)
(g)
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Figure 5: HA/2 Study: Treatment scheme of case with thin posterior mandibular ridge.
(a) Buccal view of thin posterior mandibular ridge. Recipient bone bed is prepared with
multiple decortication holes. (b) Buccal view after application of a mixture of autogenous
particulated bone and ABBM granules. Membrane is fixated with titanium pins. (c) The
resorbable collagen membrane is secured over the graft with titanium pins. (d,e) Buccal
and occlusal views of the regenerated bone. Note the good incorporation of the ABBM in
the newly formed ridge. (f) Periapical radiograph at the uncovery of the implants.
(a) (b)
(c) (d)
(e) (f)
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The flap design was chosen to ensure primary tension-free closure after the bone
grafting procedure despite the increased dimension of the ridge. A remote flap was
performed including crestal and vertical releasing incisions. A full thickness, mid-crestal
incision into the keratinized gingiva was performed with a surgical scalpel. The two
divergent vertical incisions were placed at least one tooth away from the surgical site. In
edentulous areas, the vertical incisions were placed at least 5 mm away from the
augmentation site. After primary incisions, periosteal elevators were used to reflect a full
thickness flap beyond the mucogingival junction and at least 5 mm beyond the bone
defect. In the posterior mandible, the lingual flap was elevated beyond the linea
milohyoidea and anatomical locations, like the mental and the infra-orbital nerves, were
protected.
After flap elevation and evaluation of the defect size, autogenous bone was
harvested from the retromolar regions using a trephine burr. For posterior mandibular
sites, the bone harvest was performed on the same side and the harvest site preparation
was included in the flap design. For maxillary sites, an additional flap was created in the
posterior mandible for bone harvesting.
The harvested graft was particulated in a bone mill (R. Quétin Bone-Mill,
Roswitha Quétin Dental Products, Leimen, Germany) and then either applied alone or
after preparing a 1:1 mixture with ABBM (the combination is referred to as “composite
bone graft”). The bone of the exposed augmentation site was cleaned of all soft tissue
remnants prior to grafting. Ridge measurements were taken and are described in a
section below. The recipient bone bed was prepared with multiple decorticalization holes
using a small round burr.
The collagen membrane was trimmed to the volume of the graft, and care was
taken to avoid contact with the edges of the adjacent teeth. The membrane was fixed to at
least at two points on the lingual/palatal sides with titanium pins. The composite bone
graft was placed into the defect, and the membrane was folded over and fixed in place
with additional titanium pins on the vestibular side.
For maxillary cases with a sinus proximity, additional sinus floor augmentation
was performed utilizing a surgical technique that has been described previously (35). No
other combination grafting procedures were performed.
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Once the membrane was completely secured, the flap was mobilized to permit
tension free, primary closure. A periosteal releasing incision connecting the two vertical
incisions was performed to achieve elasticity of the flap. The flap was than sutured in two
layers: first horizontal mattress sutures (GORE-TEX® CV-5 Suture, W.L. Gore &
Associates, Inc., Flagstaff, AZ) were placed 4 mm from the incision line; then, single
interrupted sutures with the same ePTFE suture were placed to close the edges of the flap,
leaving at least a 4 mm thick connective tissue layer between the membrane and the oral
epithelium. This intimate connective tissue-to-connective tissue contact provides a barrier
preventing exposure of the membrane. Vertical incisions were closed with single
interrupting sutures.
The single interrupted sutures were removed between 10 to 14 days post surgery,
and mattress sutures were removed after two to three weeks.
Measurements of the alveolar ridge width were taken intra-surgically, at the
original surgery and then after the healing phase before preparation of the implant bed.
The same calliper was used to take all measurements 2 mm apically from the top of the
crest. Periapical radiographs were taken at the abutment connection and then every 12
months thereafter with a long cone parallelling technique.
Complications in bone graft healing, such as membrane exposure, subsequent
infection, and/or morbidity associated with the harvest site, were recorded. Functionally
loaded implants were monitored to evaluate the following: Absence of pain, foreign body
sensation, dyesthesia; Radiological contact between the host bone and the implant
surface.
At the time of implant placement, cylindrical biopsies were obtained from
selected healed and augmented surgical sites using a trephine burr with an inner diameter
of 2.0 mm.
Specimens were fixated in 4 percent formaldehyde. Before processing they were
rinsed in water and dehydrated in alcohol (70%, 80%, 90%, 100%) for 3 days in each
concentration and then defatted for 1 day in Xylene (Merck, Darmstadt, Germany).
Specimens were then infiltrated, embedded and polymerized in Technovit 9100 (Heraeus
Kulzer, Wehrheim, Germany) according to the manufacturer’s instructions. After
polymerization, samples were cut in 300 µm sections using a low-speed rotary diamond
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saw Microslice TM (Metals Research, Cambrige, UK). The sections were mounted onto
opac acrylic-slides (Maertin, Freiburg, Germany) and grounded to a final thickness of
approximately 60 µm on a rotating grinding plate (Stuers, Ballerup, Denmark).
Optical microscopy specimens were stained according to the procedure described by
Richardson et al (1960). Azur II (Merck, Darmstadt, Germany) was used for the
exposition of the soft tissue and Pararosalin (Sigma-Aldrich, Deisenhofen, Germany) for
the differentiation of native and new bone.
Imaging was performed with a microscope (Carl Zeiss, Göttingen, Germany) and
a digital camera (AxioCam HRc, Carl Zeiss, Göttingen, Germany). Images were
optimized and evaluated with the program Analysis (Soft Imaging System, Münster,
Germany).
All data were analyzed by descriptive methods, and means, standard deviations,
medians, ranges, and interquartile ranges were calculated using SAS statistical software
(version 9.2, Cary, North Carolina). Implant survival was estimated using life table
analysis.
4. RESULTS
4.1 Vertical Augmentation
This retrospective study sought to encompass the scope of clinical practice where
vertical bone augmentation is required for the purpose of implant placement: 82 implants
were placed in 35 patients with 36 three-dimensional ridge defects ranging from 2 mm to
12 mm. Thirty-three patients (94.3%) were partially edentulous, and 2 (5.7%) were
completely edentulous. Fourteen (40%) patients were men and 21 (60%) were women,
and the mean age was 44.9 years (range, 19 to 72 years). A staged approach that allowed
the graft to heal uneventfully before implant placement was used in most cases.
Table 1 provides treatment approaches of the patient sample. The patients treated with
the simultaneous approach had less severe vertical defects, with a maximum defect size
of 4 mm. With one exception, intraoral bone grafts were used; the graft was taken from
the retromolar area in 21 cases (60%) and the chin in 13 cases (37.14%) (18). In 1 patient
(2.8%), bone was harvested from the hip.
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Table 1: Vertical Augmentation Study: Distribution and Surgical Approach in the
3 Treatment Groups
Distribution and Surgical Approach
Treatment
Groups
# Patients # Defects # Implants Surgical Approach
(no. and %)
Simultaneous Staged
A 12 12 12 4 (30.8) 9 (69.2)
B 16 16 42 2 (12.5) 14 (87.5)
C 7 8 28 0 (0.0) 8 (100.0)
Total 35 36 82 6 31
The implants used in this study were all commercially available from the same
manufacturer at the time of the respective surgery. Thirteen acid-etched, SteriOss (Nobel
Biocare, Yorba Linda, CA), 66 anodized-surface, Branemark TiUnite (Nobel Biocare),
and 3 anodized-surface, Replace TiUnite (Nobel Biocare) implants were placed in the 35
patients . All patients presented with vertical bone defects (see Figure 6) and were
divided into 3 treatment groups: Group A (12 patients) had single missing teeth, group B
(16 patients) had multiple missing teeth, and group C (7 patients/8 defects) had vertical
defects in the posterior maxilla only and were treated simultaneously with sinus and
vertical augmentation (see Figure 7).
Figure 6: Vertical Augmentation Study: Representative case with multiple missing
teeth (treatment group B). (a) Atrophic posterior mandibular area. (b) Particulated chin
bone graft is placed on the ridge. The cortical bone was perforated, and the membrane
was secured on the lingual side before applying bone graft. (c) the membrane is secured
over the graft with titanium pins. (d) Three implants are in place in the newly formed
posterior mandibular ridge. Note the well-integrated bone graft. (e) Periapical radiograph
at abutment connection. (f) Periapical radiograph at 3-year follow-up with implant in
function. (g) Clinical view demonstrates healthy peri-implant mucosa.
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(6a) (6b)
(6c) (6d)
(6e) (6f)
28
(6g)
Figure 7. Vertical Augmentation Study: Representative case requiring posterior
maxillary bone regeneration (treatment group C). (a). Vertical defect in the posterior
maxilla. (b) Panoramic radiograph shows defects after treatment with sinus augmentation
and vertical GBR. (c,d) After 9 months of uneventful healing, complete vertical bone
gain is demonstrated.(e) Radiographs of implants at abutment connection. (f)
Radiographs of implants after 4 years of loading. (g) Definitive implant-supported
complete fixed prosthesis.
(7a) (7b)
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(7c) (7d)
(7e) (7f)
(7g)
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Bone regeneration was evaluated clinically at the time of membrane removal. In
general, all treated defect sites exhibited excellent bone formation, with an overall
average of 5.5 mm (SD 2.29) of vertical augmentation (Table 2). None of the patients
showed less bone regeneration than the space created by the membrane (Figures 6 and
7), with one exception. This group B patient developed a fistula on top of the membrane
area 2 weeks after bone grafting. The surgical site was reopened and the membrane was
removed carefully so that the graft was not disturbed. There was no visible infection of
the graft. After gentle irrigation with saline, a resorbable collagen membrane (Bio-Gide)
was placed over the graft, and the flap was closed and permitted to heal for an additional
7 months; at this point, implants were placed successfully. At the time of implant
placement, 5 mm of the original vertical deficiency were still present, along with minimal
vertical gain (2 mm).
Table 2: Vertical Augmentation Study: Overall Augmentation Results
Treatment Group Mean (mm) SD (mm) Range (mm)
A 4.7 1.67 3.0 – 9.0
B 5.1 2.13 2.0 – 8.0
C 7.4 2.56 4.0 – 12.0
Overall 5.5 2.29 2.0 – 12.0
Regardless of which site was used for bone harvesting, there appeared to be no
difference in the results in terms of bone quality and quantity at implant placement or
during the follow-up period when implants were assessed clinically and radiographically.
Throughout the period of the study, no early or late resorption of the newly formed bone
crest was noted. The use of collagen membranes at the time of implant placement in
group C sites was strictly empirical, and it was not possible to evaluate whether they were
of any benefit in maintaining bone dimensions.
All implants were placed according to their predetermined optimal prosthetic
positions. At the time of abutment connection, all implants were stable and were fully
embedded within bone.
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After the last exam for the cohort in this retrospective study, all patients had
comfortable prostheses in place; all implants were still in function; and no patients
reported any complaints of foreign body sensation, pain or dysesthesia. Intraoral
examinations demonstrated healthy peri-implant mucosa without suppuration, swelling or
redness at any implant sites. The mean probing depth was 3.03 mm (SD 0.61).
Two patients dropped out of the study after successful treatment. One patient in
group A was lost to follow-up after the abutment connection, refused a radiographic
exam, and consequently could not be evaluated at the 1-year evaluation. The other
patient was in group B and became lost to follow-up after the 1-year evaluation.
In the 81 consecutively treated implants that were evaluated clinically and
radiographically after the abutment connection, the period of functional loading in this
study ranged from 1 to 6 years (mean: 40.3 months), and the mean radiographic follow-
up was 34.2 months. At the 1-year examination, the mean crestal bone remodeling value
for the 81 implants was 1.01mm (SD 0.57), and in most cases, the first bone-implant
contact was located near the first implant thread. The mean marginal bone remodeling for
the 81 implants throughout the study is provided in Table 3. There were no statistically
significant differences between the 3 groups in mean marginal bone remodeling, and the
crestal bone remained stable throughout the follow-up period.
Table 3 Mean Marginal Bone Loss Around Implants at Different Time Periods (in
mm)
Time
Bone Loss
Group A
Group B
Group C Overall
Mean
(SD)
n† Mean
(SD)
n† Mean
(SD)
n† Mean
(SD)
n†
Abutment
Connection
0.47
(0.61)
11 0.39
(0.47)
42 0.36
(0.58)
28 0.39
(0.53)
81
1Y 0.69
(0.55)
11 1.03
(0.53)
42 1.12
(0.58)
28 1.01
(0.57)
81
2Y 0.03
(0.17)
10 0.02
(0.32)
32 -0.15
(0.29)
25 -0.05
(0.28)
67
3Y 0.11
(0.22)
6 0.02
(0.2)
24 0.11
(0.1)
19 0.06
(0.18)
49
4Y -0.08
(0.07)
3 -0.02
(0.14)
15 0.0
(0.14)
17 -0.02
(0.13)
35
32
5Y -0.28 1 0.03
(0.1)
6 0.03
(0.12)
9 0.01
(0.13)
16
6Y 0.05
(0.0)
3 0.0
(0.12)
4 0.02
(0.1)
7
† = Number of patients who attended the respective follow up visit as a part of this
retrospective study.
All of the examined 81 implants survived (Tables 4 and 5). Only 3 implants in
group B showed increased bone remodeling (slightly more than 2 mm), and these were
not considered clinically successful.
Table 4: Vertical Augmentation Study: Life Table Analysis of Implants: Overall
Cumulative Success Rates
Time
Implants
Cumulative
Success
Rate*
Standard
Error
# Surveyed # Failures # Censored
Placement to
Loading
82 0 0 100.0% 0.0%
Loading to 1
Year
82 0 1 100.0% 0.0%
1 Year to 2
Years
81 1** 13 98.7% 1.3%
2 Years to 3
Years
67 1† 17 97.0% 2.1%
3 Years to 4
Years
49 1†† 13 94.7% 3.1%
4 Years to 5
Years
35 0 19 94.7% 3.7%
5 Years to 6
Years
16 0 9 94.7% 5.5%
6 Years to 7
Years
7 0 7 94.7% 8.2%
* Based on implants that were evaluated in the respective follow-up period.
** Patient in Group B who became lost to follow-up after the 1-year evaluation. One of
the patient’s 2 treated defects exhibited 2.5 mm bone remodeling.
† There was 2.2 mm of bone remodeling in 1 implant in Group B .
†† One implant in group B had 1.62 mm bone remodeling at the 1-year evaluation, and the
amount of bone remodeling had increased to 2.38 mm at the 3-year evaluation.
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Table 5: Vertical Augmentation Study: Life Table Analysis of Implants
Time Implants Cumulative
Success
Rate*
Standard
Error# of Implants # of Failures # Censored
Placement to Loading
Group A 12 0 0 100.0% 0.0%
Group B 42 0 0 100.0% 0.0%
Group C 28 0 0 100.0% 0.0%
Loading to 1 Year
Group A 12 0 1 100.0% 0.0%
Group B 42 0 0 100.0% 0.0%
Group C 28 0 0 100.0% 0.0%
1 Year to 2 Years
Group A 11 0 1 100.0% 0.0%
Group B 42 1 9 97.3% 2.5%
Group C 28 0 3 100.0% 0.0%
2 Years to 3 Years
Group A 10 0 4 100.0% 0.0%
Group B 32 1 7 93.9% 4.1%
Group C 25 0 6 100.0% 0.0%
3 Years to 4 Years
Group A 6 0 3 100.0% 0.0%
Group B 24 1 8 89.2% 6.0%
Group C 19 0 2 100.0% 0.0%
4 Years to 5 Years
Group A 3 0 2 100.0% 0.0%
Group B 15 0 9 89.2% 7.6%
Group C 17 0 8 100.0% 0.0%
5 Years to 6 Years
Group A 1 0 1 100.0% 0.0%
Group B 6 0 3 89.2% 12.0%
Group C 9 0 5 100.0% 0.0%
6 Years to 7 Years
Group A 0 0 0 N/A N/A
Group B 3 0 3 89.2% 16.9%
Group C 4 0 4 100.0% 0.0%
* Based on implants that had been evaluated in the respective follow-up period.
N/A = Not applicable.
4.2 Horizontal Augmentation Utilizing a New Synthetic Membrane (HA/1).
This case series reported on patients presenting to a clinical practice and requiring
horizontal bone augmentation for the purpose of implant placement. The indication for
34
horizontal ridge augmentation generally resulted from a lack of horizontal bone width in
the posterior maxilla or mandible.
Twenty-two (22) patients with 25 surgical sites presented posterior knife-edge
ridges with an insufficient width for implant placement (Cawood-Howell class IV). All
patients presented with a horizontal ridge of 4 mm or less and needed horizontal ridge
augmentation prior to dental implant placement (Table 6). For the maxillary cases, if an
additional sinus proximity was present, a sinus floor augmentation was carried out
simultaneously (17 out of 21 maxillary cases).
Table 6: Horizontal Augmentation Study (HA/1): Surgical Sites Treated with
Horizontal Ridge Augmentation for Subsequent Implant Placement
Patient #
(Surgical
Site #)
Gender Age
(years)
Maxilla /
Mandible
Graft
Composition
Healing Time
(months)
Histology
Graft Implant
1 (1) M 50 Maxilla Autograft 6.5 6.8 yes
2 (2) F 52 Maxilla Autograft 6.3 6.0 --
3 (3) F 57 Maxilla Autograft 6.3 5.6 yes
4 (4) F 52 Maxilla Autograft 10.8 5.8 yes
5 (5, 6) F 47 Maxilla Autograft 6.4 6.0 --
Maxilla Autograft +
ABBM
6.3 6.0 --
6 (7) M 59 Maxilla Autograft 6.3 5.4 --
7 (8) F 30 Maxilla Autograft 6.5 6.0 --
8 (9) F 50 Maxilla Autograft +
ABBM
11.4 7.5 --
9 (10) F 48 Maxilla Autograft +
ABBM
6.0 8.1 --
10 (11) F 42 Maxilla Autograft +
ABBM
6.0 5.3 --
11 (12) F 52 Maxilla Autograft +
ABBM
6.4 5.3 yes
12 (13) F 60 Maxilla Autograft +
ABBM
6.6 6.7 yes
13 (14) F 38 Maxilla Autograft +
ABBM
5.8 4.9 --
14 (15, 16) F 63 Maxilla Autograft +
ABBM
10.0 11.7 yes
Maxilla Autograft +
ABBM
10.0 11.7 --
15 (17) F 42 Maxilla Autograft +
ABBM
13.1 10.4 --
16 (18) F 58 Maxilla Autograft + 10.2 6.0 --
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Patient #
(Surgical
Site #)
Gender Age
(years)
Maxilla /
Mandible
Graft
Composition
Healing Time
(months)
Histology
Graft Implant
ABBM
17 (19) F 51 Mandible Autograft +
ABBM
6.3 6.4 --
18 (20) M 51 Maxilla Autograft +
ABBM
7.1 8.2 --
19 (21, 22) M 47 Mandible Autograft +
ABBM
11.3 6.0 --
Maxilla Autograft +
ABBM
10.0 7.5 --
20 (23) F 50 Mandible Autograft +
ABBM
7.3 5.1 --
21 (24) F 45 Mandible Autograft +
ABBM
8.0 7.0 --
22 (25) M 54 Maxilla Autograft +
ABBM
12.0 6.0 --
N (Data
Available)
22 25 25 6
Mean (SD) -- 49.91
(7.60)
-- -- 8.12
(2.32)
6.86
(1.89)
--
Median -- 50.50 -- -- 6.60 6.00 --
Interquartile
Range
(47.0,
54.0)
(6.3,
10.0)
(5.8,
7.5)
--
Range (30,
63)
(5.8,
13.1)
(4.9,
11.7)
--
SD = Standard Deviation
Autograft = Autogenous Bone
ABBM = Anorganic bovine-derived bone mineral
Fifty-eight (58) implants were placed in 22 patients with 25 knife-edge ridges (17
females and 5 males with a mean age of 50 years). Intraoperative measurements
indicated an average residual bone width of 2.20 mm ± 1.00 mm (range 1–4 mm) (Table
7).
Table 7: Horizontal Augmentation Study (HA/1): Measurements of the Ridges
Before and After Augmentation
Surgical Site
(#)
Ridge Width (mm) Implants
Placed (#)
Follow-up
(months)Baseline Re-entry Gain
1 2 8 6 2 66
2 4 8 6 2 66
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Surgical Site
(#)
Ridge Width (mm) Implants
Placed (#)
Follow-up
(months)Baseline Re-entry Gain
3 1 8 7 3 64
4 4 8 4 2 59
5 2 8 6 2 62
6 2 7 5 1 34
7 3 9 6 3 62
8 2 6 4 1 59
9 3 9 6 1 46
10 2 6 4 1 50
11 4 10 6 1 50
12 3 9 6 3 49
13 3 8 5 3 48
14 3 7 4 3 47
15 1 9 8 4 40
16 1 5 4 4 40
17 1 7 6 1 37
18 2 8 6 2 37
19 2 8 6 3 40
20 1 8 7 3 37
21 3 7 4 2 32
22 2 5 3 2 32
23 1 10 9 3 34
24 1 8 7 3 30
25 2 6 4 3 26
N (Data
Available)
25 25 25 25 25
Mean (SD) 2.20 (1.00) 7.68 (1.35) 5.56 (1.45) 2.32 (0.95) 45.88
(12.43)
Median 2.00 8.00 6.00 2.00 46.00
Interquartile
Range
(1.0, 3.0) (7.0, 8.0) (4.0, 6.0) (2.0, 3.0) (37.0, 59.0)
Range (1, 4) (5, 10) (3, 9) (1, 4) (26, 66)
SD = Standard Deviation
All ridges were of insufficient width to place dental implants, as generally at least
6 mm are required (Esposito et al 2006a). A comparison between the baseline ridge
width for the maxilla (84.0% of the surgical sites) and the mandible (16.0 % of the
surgical sites) showed a mean residual ridge of 2.29 mm for the maxilla and 1.75 mm for
the mandible.
After horizontal augmentation and a mean graft healing period of 8.12 months ±
2.32 months (range 5.8 – 13.1 months) the mean ridge width was 7.68 mm ± 1.35 mm ,
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giving an increase of 5.56 mm ± 1.45 mm in ridge width. After the graft healing period,
a total of 58 implants with an anodized TiUnite® surface (Brånemark System®, Nobel
Biocare, Göteberg, Sweden) were placed. See Table 8.
Of the 58 implants placed, 43 implants were placed in sites augmented with the
combination of ABBM and autogenous bone (74.1%), and 15 implants were placed into
sites augmented only with autogenous bone (25.9%) (Table 7). Implants were either
3.75 mm or 4.0 mm in diameter, and implant lengths ranged from 8.5 mm to 15 mm, with
the majority of implants being 13 mm or 15 mm in length (Table 8).
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Table 8: Horizontal Augmentation Study (HA/1): Sizes of Implants Placed
Implant
Length (mm)
Location of Implant Placement Total
Maxilla Mandible
Upper
Right
Upper Left Lower
Right
Lower Left
3.75 mm Diameter
8.5 -- -- 1 2 3
10 -- -- 3 1 4
11.5 2 1 2 -- 5
13 8 11 -- -- 19
15 -- 1 -- -- 1
4.0 mm Diameter
8.5 -- -- -- 2 2
13 5 7 -- -- 12
15 7 5 -- -- 12
Total 22 25 6 5 58
The graft and implant healing periods were uneventful in all cases, and no
complications, such as membrane exposure, infections, or harvest site morbidity, were
observed. No residual pieces of the membrane were observed at the second stage surgery.
Postoperative swelling of the donor sites was remarkable in most cases with a maximum
swelling at 48 hours postoperatively. Swelling gradually subsided but was still visible at
one week and disappeared completely after ten days. Postoperative discomfort was
primarily associated with tension from the swelling, but pain was minimal. No major
complications, such as haemorrhage, postoperative infection, mandibular fracture or
neurosensory disturbances, occurred in any patients in this case series.
Overall the experimental membrane used in these augmentations showed no
device-related side effects. Healing was similar for the mandibular and maxilliary cases
as well as for the cases solely augmented with autograft or with a mixture of ABBM and
autograft. Upon reopening of the surgical site at implant placement, the tissue beneath
appeared healthy, with a healthy periosteal layer between the soft tissue and the bone,
similar to results previously reported for non-resorbable and collagen membranes (Buser
et al 1996; Hämmerle et al 2008).
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After on average of 6.86 months implant healing time (SD 1.89 months, range 4.9
– 11.7 months), the healing abutments were placed in the 25 surgical sites. In three
cases, primary implant stability was sufficient to place the healing abutments at implant
placement. All implants appeared clinically stable upon reopening and were maintained
for provisional and definitive prosthetic restoration.
All 58 implants have survived to date (100.0% at all time points; life table
analysis) with an average follow-up of 45.88 months ± 12.43 months. There does not
appear to be any difference in implant survival between implants placed in the mandible
or the maxilla, or between sites augmented solely with autograft or with a combination of
autogenous bone and ABBM.
In total, 6 biopsies were evaluated, three from surgical sites treated with
autogenous bone only and three from surgical sites treated with a mixture of autogenous
bone and ABBM. Representative histology is presented in Figure 8.
Figure 8: HA/1 Study: Histologic assessment of the regenerated area. Healing time 6.6.
months; Maxilla; Surgical Site 13. (a) The local bone (knife-edge ridge) can be seen on
the left side. The right side shows the mixture of autogenous bone and ABBM for ridge
augmentation. ABBM particles are connected by a dense network of newly formed bone.
(b) Compact augmentation with well integrated ABBM particles. The bone surrounding
the particles is of variable matureness.
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The original intention was to evaluate biopsy specimens from each augmented
surgical site. However, due to problems with staining and storage of the specimens, only
six of the specimens could be histologically evaluated to differentiate between the pre-
existing bone, newly formed bone, and resorbable barrier membrane. As several of the
maxillary cases also included a simultaneous sinus floor elevation, this was always
evident in the augmentation and was usually observed in the biopsy specimen. In two of
the sites augmented with ABBM and autogenous bone, the horizontally augmented ridge
could be distinguished in the histology. Both specimens demonstrated newly mineralized
bone in various degrees of maturation. In one histological specimen, the cortical plate of
the former knife-edge ridge was observed, and the augmentation area showed the ABBM
being connected by a dense network of newly formed bone. In this specimen, only very
small amounts of the harvested autogenous bone could be observed. Since there was no
sign of resorption of the ABBM particles, it was assumed that the autogenous bone used
for augmentation has been resorbed and replaced by newly formed bone. There was no
histological evidence of the GBR membrane.
Even though there were a limited number of histological specimens that could be
analysed, no difference in the amount of newly formed bone observed between the apical
and coronal part of the biopsies could be observed.
4.3 Horizontal Augmentation Utilizing a Native, Bilayer Collagen Membrane
(HA/2)
This case series reported on patients presenting to a clinical practice and requiring
horizontal bone augmentation for the purpose of implant placement. The indication for
horizontal ridge augmentation generally resulted from a lack of horizontal bone width in
the posterior maxilla or mandible. All patients presented with a horizontal ridge of 4 mm
or less and in need of horizontal ridge augmentation prior to dental implant placement
(Table 9). For the maxillary cases, if an additional sinus proximity was present, a sinus
floor augmentation was carried out simultaneously (16 out of 18 maxillary cases).
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Table 9: Horizontal Augmentation Study (HA/2): Surgical Sites Treated with
Horizontal Ridge Augmentation for Subsequent Implant Placement
Patient #
(Surgical
Site #)
Gender Age
(years)
Maxilla /
Mandible
Healing Time (months) Histology
Graft Implant
1 (1) Male 62 Maxilla 8.00 6.00 Yes
2 (1) Male 58 Maxilla 8.00 7.75 Yes
2 (2) Mandible 9.25 6.00 Yes
3 (1) Female 72 Maxilla 13.00 6.00
4 (1) Female 37 Mandible 13.25 5.25
5 (1) Male 57 Maxilla 8.00 6.25
5 (2) Maxilla 8.00 6.25
6 (1) Female 49 Mandible 7.5 4.25
7 (1) Male 50 Maxilla 7.00 6.25
8 (1) Male 62 Mandible 8.00 5.75
9 (1) Female 61 Maxilla 8.25 5.75 Yes
9 (2) Maxilla 10.25 5.75
10 (1) Male 34 Maxilla 7.00 20.25 Yes
11 (1) Female 57 Mandible 6.50 3.50
12 (1) Female 53 Mandible 6.00 7.75 Yes
13 (1) Female 62 Mandible 8.00 4.75
14 (1) Male 59 Maxilla 10.00 6.00 Yes
15 (1) Female 30 Maxilla 7.75 5.50
16 (1) Female 47 Mandible 7.50 9.00
16 (2) Mandible 7.50 9.00
17 (1) Female 39 Maxilla 8.25 14.75 Yes
17 (2) Mandible 13.00 14.00
18 (1) Female 71 Maxilla 10.00 6.00
19 (1) Female 55 Mandible 9.25 10.00
20 (1) Female 54 Maxilla 11.25 6.00 Yes
21 (1) Female 61 Maxilla 8.50 6.00
21 (2) Maxilla 8.50 6.00
22 (1) Male 38 Maxilla 9.25 5.25
23 (1) Male 61 Mandible 8.00 6.00
24 (1) Male 51 Maxilla 7.00 4.50
25 (1) Female 37 Mandible 14.00 3.25
N (Data
Available)
25 31 31
Mean (SD) 52.7
(11.4)
8.90 (2.06) 7.06 (3.52)
Median 55.0 8.00 6.00
Interquar-
tile Range
(47.0,
61.0)
(7.5, 10.0) (5.5, 7.75)
Range (30, 72) (6.0, 14.0) (3.25,
20.25)
SD = Standard Deviation
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Seventy-eight (78) implants were placed in 25 patients with 31 knife-edge ridges
(15 females and 10 males with a mean age of 52.7 years (Table 9).
Intraoperative measurements indicated an average residual bone width of 2.20
mm (SD=0.65 mm; range 1–4 mm) (Table 10).
Table 10: Horizontal Augmentation Study (HA/2): Measurements of the Ridges
Before and After Augmentation
Patient #
(Surgical
Site #)
Ridge Width (mm) Implants
Placed (#)
Follow-up
(months)Baseline Re-entry Gain
1 (1) 3.5 11.0 7.5 2 28.25
2 (1) 2.0 8.0 6.0 3 23.50
2 (2) 2.0 7.5 5.5 2 27.25
3 (1) 1.5 7.0 5.5 3 23.75
4 (1) 2.0 7.0 5.0 1 14.25
5 (1) 2.0 7.0 5.0 3 29.50
5 (2) 2.0 8.0 6.0 3 29.50
6 (1) 2.0 10.5 8.5 3 22.00
7 (1) 2.0 6.0 4.0 3 14.25
8 (1) 1.0 5.0 4.0 3 3.00
9 (1) 2.0 12.0 10.0 4 24.00
9 (2) 2.0 10.0 8.0 3 24.00
10 (1) 3.5 8.0 4.5 2 7.00
11 (1) 2.0 7.5 5.5 3 9.25
12 (1) 2.0 8.0 6.0 2 31.00
13 (1) 1.5 7.0 5.5 2 16.00
14 (1) 2.0 7.0 5.0 3 34.00
15 (1) 3.0 8.0 5.0 1 11.75
16 (1) 2.0 7.0 5.0 2 29.25
16 (2) 2.5 8.0 5.5 2 29.25
17 (1) 3.0 9.0 6.0 3 16.25
17 (2) 1.5 6.5 5.0 3 2.25
18 (1) 2.0 8.0 6.0 2 13.25
19 (1) 1.5 7.5 6.0 1 30.75
20 (1) 4.0 10.0 6.0 2 27.75
21(1) 2.5 8.0 5.5 4 12.75
21 (2) 2.5 8.0 5.5 4 12.75
22 (1) 2.0 8.0 6.0 1 16.50
23 (1) 2.5 7.5 5.0 2 23.75
24 (1) 2.0 8.0 6.0 4 39.50
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Patient #
(Surgical
Site #)
Ridge Width (mm) Implants
Placed (#)
Follow-up
(months)Baseline Re-entry Gain
25 (1) NR NR NR 2 21.75
N (Patient
Data
Available)
30 30 30 31 31
Mean (SD) 2.20 (0.65) 8.00 (1.47) 5.80 (1.26) 2.52 (0.89) 20.90 (9.34)
Median 2.00 8.00 5.50 3.00 23.50
Interquartile
Range
(2.00, 2.50) (7.00, 8.00) (5.00, 6.00) (2.00, 3.00) (13.25,
29.25)
Range (1.0, 4.0) (5.0, 12.0) (4.0, 10.0) (1.0, 4.0) (2.25, 39.50)
SD = Standard Deviation
NR = Not reported for patient with complication that resulted in minimal bone gain (2
mm)
All ridges were of insufficient width to place dental implants, as generally at least
6 mm are required (Esposito et al 2006a). A comparison between the baseline ridge
width for the maxilla (58.1% of the surgical sites) and the mandible (41.9 % of the
surgical sites) showed a mean residual ridge of 2.42 mm for the maxilla and 1.88 mm for
the mandible.
After horizontal augmentation and a mean graft healing period of 8.9 months
(SD=2.1 months; range 6.0 – 14.0 months) the mean ridge width was 8.00 mm (SD=1.47
mm), giving an increase of 5.80 mm (SD=1.26 mm) in ridge width. There were no
discernible statistical differences in bone width gain between maxillary and mandibular
sites (p=0.2405). After the graft healing period, a total of 78 implants with an anodized
TiUnite® surface (Brånemark System®, Nobel Biocare, Göteberg, Sweden) were placed.
See Table 11.
Implants were either 3.5 mm, 3.75 mm, 4.0 mm, or 4.3 mm in diameter, and
implant lengths ranged from 7.0 mm to 13 mm, with the majority of implants being 13
mm in length (Table 11).
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Table 11: Horizontal Augmentation Study (HA/2): Sizes of Implants Placed
Implant Length
(mm)
Location of Implant Placement Total
Maxilla Mandible
3.5 mm Diameter
13 1 -- 1
3.75 mm Diameter
8.5 -- 2 2
10.0 -- 8 8
11.5 2 11 13
13.0 25 -- 25
4.0 mm Diameter
7.0 -- 1 1
8.5 -- 1 1
11.5 3 4 7
13.0 19 -- 19
4.3 mm Diameter
10 -- 1 1
Total 50 28 78
With one exception, the graft and implant healing periods were uneventful in all
cases. One patient developed an abscess at the graft site (3.2%; 95% CI: 0.1%, 16.7%).
The surgical site was opened and irrigated, and the patient was given antibiotics. The
infection was treated effectively, but a major portion of the bone graft was lost and
minimal bone gain of 2 mm was achieved. The patient was successfully retreated with
grafting and subsequent implant placement. The placed implants have been loaded for
almost two years.
Postoperative swelling of the donor sites was most pronounced in most cases at
48 hours postoperatively. Swelling gradually subsided but was still visible at one week
and disappeared completely after ten days. Postoperative discomfort was primarily
associated with tension from the swelling, but pain was minimal.
No residual pieces of the membrane were observed at the second stage surgeries.
There were no device-related adverse effects related to the use of the native collagen
membrane in these augmentation procedures. Healing was similar for the mandibular
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and maxilliary cases. Upon reopening of the surgical site at implant placement, the tissue
beneath appeared healthy, with a healthy periosteal layer between the soft tissue and the
bone, similar to results previously reported for non-resorbable and collagen membranes
(Schenk et al 1994; Maiorana et al 2005).
After on average implant healing time of 7.1 months implant healing time
(SD=3.5 months; range 3.25 – 20.25 months), the healing abutments were placed in the
31 surgical sites. In seven cases, primary implant stability was sufficient to place the
healing abutments at implant placement. All implants appeared clinically stable upon
reopening and were maintained for provisional and definitive prosthetic restoration.
All 78 implants have survived to date (100.0% at all time points; life table
analysis) with an average follow-up of 20.9 months (SD=9.3 months). There does not
appear to be any difference in implant survival between implants placed in the mandible
or the maxilla.
Histological Findings:
Nine specimens were examined histologically. The histological samples were
taken at a mean 8.4 months of graft healing, during the implant placement from the
implant osteotomies utilizing a two millimeter trephine for implant site preparation.
Histomorphometric analysis demonstrated that autogenous or regenerated bone
represented a mean of 31.0% of the specimens, ABBM 25.8%, and marrow space 43.2%.
See Table 12.
Table 12: Horizontal Augmentation Study (HA/2): Histology Results
Statistic % of Specimens (N = 9)
Autogenous Bone ABBM Marrow Space
Mean 31.00 25.80 43.20
Median 31.50 20.60 38.30
Std. Dev. 10.80 14.80 10.50
Range 18.49, 53.63 9.10, 51.16 30.40, 60.18
Representative histology is presented in Figure 9. In all biopsy specimens
evaluated, ABBM was connected with a dense network of newly formed bone of various
degree of maturation. In two histologic specimens, the original cortical plate of the knife-
edge ridge was observed and the augmentation area was connected with a dense network
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of newly formed bone connected with the original bone. There was no histologic
evidence of the GBR membrane.
Figure 9: HA/2 Study: (a) Overview of a histological section taken at 8 months of graft
healing (Patient 1, Table 9). The original maxillary bone can be seen. The augmentation
area is connected with newly formed bone to the original maxillary bone (original
magnification x 50). (b) Formation of dense trabecular structures composed of newly
formed bone with integrated ABBM granules (original magnification x 100). (c, d) Mixed
deposition of lamellar and woven bone on ABBM by active osteoblasts (original
magnification x 200, x 400). Connective tissue shows no signs of inflammatory reactions
(a) (b)
(c) (d)
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5. DISCUSSION
5.1. Vertical Augmentation
Bone augmentation utilizing GBR techniques is well documented and
characterized by high predictability and survival of implants (Buser et al 2002; Nevins et
al 1998; Zitzmann et al 2001a). However, few publications have reported long-term
results on vertical ridge augmentation following GBR (Simion et al 2001, 2004). These
studies found that vertical bone regeneration of more than 4 mm could only be achieved
with the use of autogenous bone chips. This is consistent with the present study, since up
to 12 mm vertical bone gain was achieved. None of the sites showed less bone
regeneration than the space created by the membrane; however, the 1 site in which early
membrane removal was necessary showed minimal (2 mm) vertical bone gain. This
indicates that a dimensionally stable barrier, such as the titanium-reinforced e-PTFE
membrane, may be necessary for vertical augmentation.
After abutment connection, clinical follow-up demonstrated healthy peri-implant
mucosa and a mean probing depth of 3.03 mm. These values are consistent with those
reported previously in long-term studies on implants placed into native (Buser et al 1990;
Lekholm et al 1994) and regenerated bone (Buser et al 2002; Simion et al 2001).
Crestal bone remodeling was measured from the implant-abutment junction. This
showed an overall mean change of 1.01 mm in the first year and remained stable
throughout the follow-up period. Similarly, 1.32 mm of remodeling was shown
previously in a study reporting on 32 sites that were vertically augmented with
autogenous bone chips and a titanium-reinforced e-PTFE membrane (Simion et al 2001).
In the current study, there was a slight difference in the first year between the 3 groups
examined in this report. However, the differences were not statistically significant and in
fact could be expected by the span size and location of the defects.
The overall implant success rates within this study are consistent with published
long- term results of implants placed in horizontally and vertically regenerated bone
(Buser et al 2002; Simion et al 2001) and with results reported for implants placed in
native bone (Adell et al 1981, 1990; Jemt & Lekholm 1993; Lekholm et al 1994, 1999).
The overall cumulative implant survival rate of 100% and cumulative success rate of
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94.7% in this study compare favorably with the aforementioned studies on implants
placed in regenerated bone as well as native bone.
However, there was a marked difference in results reported in previous studies on
vertical GBR and the current study. Implant survival and implant success rates were 92%
and 76%, respectively, in a study that combined sinus augmentation and posterior
maxillary vertical ridge augmentation (Simion et al 2004), whereas 100% implant success
was achieved in a similar population in the current study (group C). However, in the
previous report, only machined-surface implants were used, whereas enhanced-surface
implants were used in the current study. The use of enhanced implant surfaces may have
helped, especially in the posterior maxilla where the bone quality is typically poor. Also,
in the previous report 7 patients (50%) were treated with a simultaneous technique,
whereas in the current study the same type of patients were treated with a staged
technique, which allowed more time for regenerated bone to mature prior to loading.
In the present report, the complication rate was 2.78%. This is significantly lower
than the complication rates reported in earlier clinical studies on vertical augmentation
with GBR (ranging from 12.5% to 17%), and these earlier reports also included
membrane exposures and/or subsequent infections (Tinti & Parma-Benfenati 1998;
Simion et al 1994, 1998, 2004). The technique employed in this vertical augmentation
study is essentially the same technique reported previously (Tinti & Parma-Benfenati
1998). However, this retrospective study represents the time period when vertical ridge
augmentation was considered routine clinical practice and does not represent the initial
learning curve. The results of this study indicate that (1) there can be reduced
complication rates with vertical bone regeneration, (2) implants can be placed
successfully in vertically regenerated bone, and (3) implants can survive over time with
high clinical success rates.
Some similarities and differences have been identified between the present study
and the previously reported studies. These studies should be analyzed in a meta-analytic
fashion to coalesce the data into a more meaningful finding relative to the current state of
the science on vertical augmentation. Also, since most of the vertical augmentation
studies reported in the literature have been retrospective in nature, future research should
focus on long-term, prospective studies.
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5.2 Horizontal Augmentation Utilizing a New Synthetic Membrane (HA/1).
The case series presented herein demonstrates that the combination of particulated
augmentation material (either autogenous bone alone or a combination of autogenous
bone and ABBM) and a resorbable membrane can be safely and effectively used for
horizontal augmentation of knife-edge ridges in the posterior maxilla or mandible. Even
though the healing time between grafting and implant placement can be regarded as a
compromise between the time to form sufficient amount of new bone and the need of a
timely prosthetic solution for a patient, the benefit of this two-staged procedure is that it
provides the amount of horizontal ridge width necessary to successfully place an implant.
Healing of the bone graft was uneventful for all cases in this prospective case
series. The use of the synthetic membrane reported herein has shown good soft tissue
compatibility, and no membrane exposures or infections occurred at any of the surgical
sites. Similar results of soft tissue healing have been reported for both non-resorbable e-
PTFE and resorbable synthetic and collagen membranes (Urban et al 2009a,b; Hämmerle
et al 2008; Simion et al 1997). Recently, a new synthetic membrane composed of
different resorbable materials has been used in preclinical animal models and clinical
studies with similar results and comparable soft tissue healing (Herten et al 2009; Jung et
al 2009a, b; Thoma et al 2009). Other authors, however, have reported more
spontaneous exposures of collagen and e-PTFE membranes (Lindhe et al 2003; Moses et
al 2005). Non-resorbable e-PTFE membranes are still regarded as the gold standard in
GBR, however frequently reported soft tissue problems, as well as the need to remove the
membrane, have supported the development and use of resorbable membranes (Lindhe et
al 2003; Moses et al 2005). The lack of a titanium reinforced resorbable membrane can
be overcome by secure fixation of the membrane on both the lingual/palatal and the
vestibular side. This technique immobilizes the graft material, allowing for the formation
of the desired amount of bone.
In this case series, there was a mean horizontal bone increase of 5.52 mm (± 1.40
mm), with some sites gaining up to 9 mm. Overall, only two cases resulted in a horizontal
ridge width of less than 6 mm; however, in both cases, implant placement was achieved
and have survived over 32 months months. Similarly, 4.6mm horizontal bone gain was
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reported in a study utilizing autogenous bone blocks covered with ABBM particles and
resorbable collagen membranes (von Arx & Buser 2006), whereas a somewhat less
favorable result of 3.6mm horizontal bone gain was achieved when using ABBM
particles alone as grafting material with collagen membranes (Hämmerle et al 2008). The
differences may be attributed to the use of autogenous particles mixed with ABBM,
which may have resulted in a more osteogenic graft. Also, the membrane used in this
report has a longer resorption time, which may have allowed more time for the graft to
mature.
Within the cases in this series, no differences could be detected between the sites
augmented only with autogenous bone and those augmented with a mixture of
autogenous bone and ABBM. However, the number of cases treated with autogenous
bone alone is limited. In the cases treated with the mixture of autogenous bone and
ABBM, the ABBM particles showed good incorporation with the newly formed ridge.
This is supported by the available histology of the augmentation area showing that the
ABBM was connected by a dense network of newly formed bone. In another published
report in which autogenous bone blocks were covered with ABBM particles and collagen
membranes, at re-entry the ABBM particles showed fibrous incapsulation only and no
evidence of osseous integration (von Arx & Buser 2006). This may further support the
use of particulated autogenous bone mixed with ABBM rather than ABBM layered on
autogenous bone blocks.
Since all implants have survived to date, this case series demonstrates the
feasibility of using a new resorbable membrane in GBR for horizontal ridge
augmentation. However, the high rate of implant survival reported in this case series has
to be viewed cautiously since implant success according to established methods has not
yet been investigated.
Recent reports in the literature indicate that the standard treatment of knife-edge
ridges has changed in recent years (Hämmerle et al 2008). The use of bone grafting
materials and resorbable membranes to treat knife-edge defects with horizontal
augmentation may lead to less morbidity in the treatment of patients with these defects.
In addition, the use of ABBM in these procedures may lessen the need of harvested
autogenous bone and may generally lead to decreased morbidity and therefore increased
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patient comfort and satisfaction associated with these regenerative procedures. The
absence of major complications in any of the harvest sites in this case series supports the
potential benefit of ABBM for use in these types of procedures. However, the positive
results obtained in this case series need to be proven by larger randomized and controlled
clinical trials.
5.3 Horizontal Augmentation Utilizing a Native, Bilayer Collagen Membrane
(HA/2)
The case series presented herein demonstrates that the combination of particulated
autogenous bone mixed with ABBM and a short-term resorbable, collagen membrane can
be safely and effectively used for horizontal augmentation of knife-edge ridges in the
posterior maxilla or mandible. Even though the healing time between grafting and
implant placement can be regarded as a compromise between the time to form sufficient
amount of new bone and the need of a timely prosthetic solution for a patient, the benefit
of this two-staged procedure is that it provides the amount of horizontal ridge width
necessary to successfully place an implant.
With one exception, healing of the bone graft was uneventful in this prospective
case series, and there was an infection of the bone graft in this case (3.2%). This is
similar to most recently reported complication rates on horizontal and vertical
augmentation (Buser et al 2002; Urban et al 2009a, b).
The use of the collagen membrane reported herein has shown good soft tissue
compatibility, and no membrane exposures occurred at any of the surgical sites. Similar
results of soft tissue healing have been reported for both non-resorbable e-PTFE and
resorbable synthetic and collagen membranes (Hämmerle et al 2008; Simion et al 1997;
Urban et al 2009a, b, 2011a, b). Other authors, however, have reported more
spontaneous exposures of collagen and e-PTFE membranes (Moses et al 2005; Lindhe et
al 2003). Non-resorbable e-PTFE membranes are still regarded as the gold standard in
GBR, however frequently reported soft tissue problems, as well as the need to remove the
membrane, have supported the development and use of resorbable membranes (Moses et
al 2005; Lindhe et al 2003). The lack of a titanium reinforced resorbable membrane can
be overcome by secure fixation of the membrane on both the lingual/palatal and the
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vestibular side. This technique immobilizes the graft material, allowing for the formation
of the desired amount of bone.
In this case series, there was a mean horizontal bone increase of 5.80 mm
(SD=1.26 mm), with some sites gaining up to 10.0 mm. All cases resulted in a horizontal
ridge width of at least 5 mm, and implant placement was achieved. All implants have
survived to date and are in function (2 to 40 months). Similarly, 4.6 mm horizontal bone
gain was reported in a study utilizing autogenous bone blocks covered with ABBM
particles and resorbable collagen membranes (von Arx & Buser 2006), whereas a
somewhat less favorable result of 3.6 mm horizontal bone gain was achieved when using
ABBM particles alone as grafting material with short-term resorbable, collagen
membranes (Hämmerle et al 2008). The differences may be attributed to the use of
autogenous particles mixed with ABBM, which may have resulted in a more osteogenic
graft.
In this case series treated with the mixture of autogenous bone and ABBM, the
ABBM particles showed good incorporation with the newly formed ridge. This is
supported by the available histology of the augmentation area showing that the ABBM
was connected by a dense network of newly formed bone. In another published report in
which autogenous bone blocks were covered with ABBM particles and collagen
membranes, at re-entry the ABBM particles showed fibrous incapsulation only and no
evidence of osseous integration (von Arx & Buser 2006). This may further support the
use of particulated autogenous bone mixed with ABBM rather than ABBM layered on
autogenous bone blocks.
Since all implants have survived to date, this case series demonstrates the
feasibility of using a more rapidly resorbing membrane in GBR for horizontal ridge
augmentation. However, the high rate of implant survival reported in this case series has
to be viewed cautiously since implant success according to established methods has not
yet been investigated and the implants have been followed only for short term.
Recent reports in the literature indicate that the standard treatment of knife-edge
ridges has changed in recent years (Hämmerle et al 2008; Urban et al 2011a, b). The use
of bone grafting materials and resorbable membranes to treat knife-edge defects with
horizontal augmentation may lead to less morbidity in the treatment of patients with these
54
defects. In addition, the use of ABBM in these procedures may lessen the need of
harvested autogenous bone and may generally lead to decreased morbidity and therefore
increased patient comfort and satisfaction associated with these regenerative procedures.
The absence of major complications in any of the harvest sites in this case series supports
the potential benefit of ABBM for use in these types of procedures. However, the
positive results obtained in this case series need to be proven by larger randomized and
controlled clinical trials.
6. CONCLUSIONS
6.1 Vertical Augmentation
The results of this retrospective study suggest that the following conclusions can
be made: (1) vertical augmentation with e-PTFE membranes and particulated autografts
is safe and predictable, with minimal complications; (2) clinical success and survival of
implants placed in vertically augmented bone with the GBR technique appear similar to
success and survival of implants placed in native bone under loading conditions,
regardless of the harvest site, surgical area, or defect size; and (3) the success and
survival rates of implants placed simultaneously with sinus and vertical augmentation
techniques compare favorably to those in sites requiring vertical augmentation of single-
or multiple-tooth ridge defects.
6.2 Horizontal Augmentation Utilizing a New Synthetic Membrane (HA/1).
In this case series, the treatment of horizontally deficient alveolar ridges with the
GBR technique using autogenous bone with or without the addition of ABBM and a
resorbable barrier membrane can be regarded as successful and may lead to implant
survival. The regenerated bone can lead to good osseointegration of the dental implant.
Histological evaluation of the regenerated bone has shown that the autogenous bone is
mostly resorbed and replaced by vital bone and the bone substitute particles are
connected by new vital bone.
6.3 Horizontal Augmentation Utilizing a Native, Bilayer Collagen Membrane
(HA/2)
55
In this case series, the treatment of horizontally deficient alveolar ridges with the
GBR technique using autogenous bone mixed with ABBM and a native collagen
resorbable barrier membrane can be regarded as successful and may lead to implant
survival. Within the timeframe of the study the regenerated bone leads to good
osseointegration of the dental implant. Histologic evaluation showed that ABBM was
connected with a dense network of newly formed bone of various degree of maturation.
7. FUTURE PERSPECTIVES IN RIDGE AUGMENTATION.
In order to reduce morbidity of harvesting autogenous bone, some recombinant
growth factors have recently been investigated.
It has been demonstrated in a canine preclinical study that rhBMP-2 induced bone
allows installation, osseointegration, and long-term functional loading of machined,
threaded, titanium dental implants (Jovanovic et al 2003). Publications have reported on
the clinical use of rhBMP-2 on an absorbable collagen sponge in a phase II study (three
treatment groups: two doses of rhBMP-2 and autograft) and a pivotal study (two
treatment groups: one dose of rhBMP-2 and autograft) for sinus floor augmentation
(Boyne et al 2005; Triplett et al 2009). Both studies found that the regenerated bone was
sufficient to place and functionally load implants. In addition, Triplett et al noted that in
the pivotal study there was “a 17% rate of long-term parasthesia, pain, or gait disturbance
related to the bone graft harvest” in the autograft treatment group (2009).
The use of platelet-derived growth factor (PDGF) in combination with
deproteinized bovine bone block has also been studied in a dog model (Simion et al.
2006). The results of this preclinical canine study demonstrated that purified recombinant
PDGF-BB, used in combination with a deproteinized bovine block, and without
placement of a barrier membrane, has the potential to regenerate significant amounts of
new bone in severe mandibular ridge defects.
Several case studies utilizing different versions of the above mentioned
combinations of autogenous bone, ABBM and rhPDGF-BB were recently published
(Simion et al. 2007, 2008, Urban et al. 2009, 2011c) and demonstrated successful
histological and clinical results.
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This modality has the potential to completely eliminate the need of bone
harvesting and any bone filler materials, and preliminary results are encouraging.
However, the clinician must recognize that there is limited clinical information available
on these new modalities, and no information on resorption of the regenerated bone,
implant survival and crestal remodeling around implants. Further documentation from
long-term, randomized, controlled clinical studies are necessary to recommend these new
treatment modalities in everyday clinical practice.
8. OVERALL CONCLUSIONS
Vertical and horizontal augmentation with GBR represents the current state of the science
in implant dentistry. Given adequate care in selecting cases for these procedures and
complying with surgical and postsurgical treatment protocols, the results are beneficial to
the patient with a relatively low risk of complications. Tissue engineering may hold the
promise of a new vertical and horizontal augmentation procedure, but the potential of this
treatment modality in everyday clinical practice will require the results of long-term,
randomized, controlled clinical studies to confirm the risk/benefit as compared to vertical
and horizontal augmentation with GBR.
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